evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
18550,GENE_SUMMARY,,SETD2 encodes a tumor suppressor and H3K36 trimethylase. Mutations in this gene have been identified in a variety of cancer types.,,2017-04-12,,29072,SETD2,SET domain containing 2,False,ENST00000409792,NM_014159.6,HIF-1,HYPB,LLS,p231HBP,KMT3A,SET2,HIP-1,HSPC069,HBP231,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18551,GENE_BACKGROUND,,"SETD2 encodes a chromatin modulating enzyme that functions by site specific trimethylation of histone H3K36. It was originally identified as a contributing enzyme in the pathogenesis of Huntington Disease and thus was initially named Huntington Interacting Protein B (HYPB) (PMID: 9700202). Histone methylation is a highly controlled biological process that regulates gene expression by altering the ability of RNA polymerase II to interact with DNA and thus initiate transcription (PMID:16118227, 25123655). Additionally, the SETD2-regulated H3K36 histone mark has been shown to play a role in regulating DNA mismatch repair. This suggests that inactivation of this protein can lead to enhanced genetic instability, enrichment of nonsense and frameshift mutations and ultimately oncogenic transformation of cells (PMID: 23622243, 25123655, 25728682, 24931610). Importantly, SETD2-mutant renal tumors failed to activate the p53 tumor suppressor, thus providing an alternative pathway for the inactivation of p53 that leads to defects in DNA damage repair (PMID: 24843002).",,2017-04-12,,29072,SETD2,SET domain containing 2,False,ENST00000409792,NM_014159.6,HIF-1,HYPB,LLS,p231HBP,KMT3A,SET2,HIP-1,HSPC069,HBP231,True,24843002,SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.,eLife,2018-05-06T20:14:00,3,,e02482,Carvalho S et al,doi: 10.7554/eLife.02482,,0001-05-06,,25728682,SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.,Oncogene,2018-11-12T20:15:00,34,46,5699-708,Kanu N et al,doi: 10.1038/onc.2015.24,,2018-11-12T07:08:00,,9700202,Huntingtin interacts with a family of WW domain proteins.,Human molecular genetics,0001-09-01,7,9,1463-74,Faber PW et al,,,0001-09-01,,25123655,Role of somatic cancer mutations in human protein lysine methyltransferases.,Biochimica et biophysica acta,2017-12-01T20:14:00,1846,2,366-79,Kudithipudi S et al,doi: 10.1016/j.bbcan.2014.08.002,,0001-12-01,,23622243,The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSÎ±.,Cell,2018-04-25T20:13:00,153,3,590-600,Li F et al,doi: 10.1016/j.cell.2013.03.025,,2018-04-25T06:00:00,,16118227,Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase.,The Journal of biological chemistry,2018-10-21T20:05:00,280,42,35261-71,0001-01-07,,,0001-10-21,,24931610,SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.,Cell reports,2018-06-26T20:14:00,7,6,2006-18,Pfister SX et al,doi: 10.1016/j.celrep.2014.05.026,,0001-06-26,
